Ability of suvorexant to prevent delirium in patients in the intensive care unit: a randomized controlled trial
Open Access
- 19 August 2018
- journal article
- research article
- Published by Wiley in Acute Medicine & Surgery
- Vol. 5 (4) , 362-368
Abstract
Aim: There are no effective, tolerable, and established medications for preventing delirium in critically ill patients admitted to the intensive care unit (ICU). We investigated whether suvorexant was effective in preventing ICU delirium.Methods: This randomized controlled study evaluated 70 adult patients (age ≥20 years) admitted to the mixed medical ICU of the Tokyo Medical University Hospital (Tokyo, Japan) between May 2015 and February 2017. Patients were randomized using a sealed envelope method to receive either suvorexant (n = 34; 15 mg for elderly patients and 20 mg for younger adults) or conventional treatment (n = 36) for a 7‐day period. The primary outcome was delirium incidence based on the definition in the 5th edition of the Diagnostic and Statistical Manual of Mental Disorders.Results: No significant between‐group differences were observed in the demographic or clinical characteristics. Kaplan−Meier estimates revealed that time to delirium onset was significantly longer in the suvorexant group than in the conventional group (P < 0.05).Conclusion: Suvorexant might be effective in preventing delirium in ICU patients.Keywords
This publication has 30 references indexed in Scilit:
- Development and validation of PRE-DELIRIC (PREdiction of DELIRium in ICu patients) delirium prediction model for intensive care patients: observational multicentre studyBMJ, 2012
- Melatonin decreases delirium in elderly patients: A randomized, placebo‐controlled trialInternational Journal of Geriatric Psychiatry, 2010
- Delirium as a predictor of long-term cognitive impairment in survivors of critical illnessCritical Care Medicine, 2010
- Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: The MIND randomized, placebo-controlled trial*Critical Care Medicine, 2010
- Efficacy and safety of quetiapine in critically ill patients with delirium: A prospective, multicenter, randomized, double-blind, placebo-controlled pilot study*Critical Care Medicine, 2010
- Pharmacological Management of Delirium in Hospitalized Adults – A Systematic Evidence ReviewJournal of General Internal Medicine, 2009
- Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac DeathNew England Journal of Medicine, 2009
- Delirium in Older PersonsNew England Journal of Medicine, 2006
- The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failureIntensive Care Medicine, 1996
- APACHE IICritical Care Medicine, 1985